HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
William C Spanos Selected Research
William C Spanos Research Topics
Disease
17
Neoplasms (Cancer)
05/2022 - 11/2009
11
Squamous Cell Carcinoma of Head and Neck
05/2022 - 11/2005
7
Head and Neck Neoplasms (Head and Neck Cancer)
10/2021 - 11/2009
2
Infections
10/2021 - 01/2021
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 01/2016
2
Neoplasm Metastasis (Metastasis)
04/2016 - 04/2016
1
Fever (Fevers)
01/2022
1
Surgical Wound
01/2021
1
Wounds and Injuries (Trauma)
01/2021
1
Experimental Melanoma
01/2019
1
Fibrosis (Cirrhosis)
01/2018
1
Neutropenia
07/2017
1
Lymphatic Metastasis
04/2016
1
Paralysis (Palsy)
10/2009
1
Patent Ductus Arteriosus
10/2009
1
Birth Weight (Birth Weights)
10/2009
1
Cytomegalovirus Infections (Inclusion Disease)
11/2005
Drug/Important Bio-Agent (IBA)
5
Cisplatin (Platino)
FDA Link
Generic
05/2022 - 11/2009
3
Immune Checkpoint Inhibitors
IBA
01/2021 - 01/2016
2
Pharmaceutical Preparations
IBA
01/2022 - 01/2021
2
Carcinogens
IBA
10/2021 - 01/2021
2
Oncogene Proteins (Oncogene Protein)
IBA
10/2021 - 11/2019
2
Cetuximab (Erbitux)
FDA Link
03/2021 - 01/2021
2
130-nm albumin-bound paclitaxel
IBA
03/2021 - 01/2021
2
pembrolizumab
IBA
01/2020 - 01/2016
2
Chemokines
IBA
01/2020 - 11/2019
2
Antigens
IBA
11/2019 - 01/2019
2
Proteins (Proteins, Gene)
FDA Link
07/2013 - 02/2008
1
Pyruvate Dehydrogenase Acetyl-Transferring Kinase
IBA
01/2022
1
Oxidoreductases (Dehydrogenase)
IBA
01/2022
1
Pyruvic Acid (Pyruvate)
IBA
01/2022
1
Lactic Acid (Lactate)
FDA Link
Generic
01/2022
1
Biological Products
IBA
10/2021
1
Panitumumab (Vectibix)
FDA Link
05/2021
1
ErbB Receptors (EGF Receptor)
IBA
05/2021
1
Albumin-Bound Paclitaxel
FDA Link
01/2021
1
Nivolumab
IBA
01/2021
1
Albumins
IBA
01/2021
1
Carboplatin (JM8)
FDA Link
Generic
01/2021
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2021
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2019
1
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
01/2019
1
Immunomodulating Agents
IBA
01/2019
1
CTLA-4 Antigen
IBA
01/2019
1
Adrenergic Agents (Adrenergic Drugs)
IBA
10/2018
1
Propranolol (Inderal)
FDA Link
Generic
10/2018
1
Superoxide Dismutase
IBA
01/2018
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
07/2017
1
Filgrastim (Neupogen)
FDA Link
07/2017
1
Anti-Bacterial Agents (Antibiotics)
IBA
07/2017
1
Sirolimus (Rapamycin)
FDA Link
04/2016
1
Membrane Proteins (Integral Membrane Proteins)
IBA
07/2013
1
Granzymes (Granzyme)
IBA
07/2013
1
Interferon-gamma (Interferon, gamma)
IBA
07/2013
1
Viral DNA
IBA
11/2005
1
Cidofovir (Vistide)
FDA Link
11/2005
Therapy/Procedure
8
Therapeutics
01/2022 - 11/2009
4
Chemoradiotherapy
05/2022 - 01/2020
4
Radiotherapy
01/2020 - 11/2009
3
Drug Therapy (Chemotherapy)
01/2020 - 07/2013
2
Immunotherapy
01/2021 - 01/2020
1
Induction Chemotherapy
03/2021
1
Neoadjuvant Therapy
01/2021
1
Immunomodulation
01/2019
1
Physical Therapy Modalities (Physical Therapy Technique)
01/2018
1
Ligation
10/2009
1
Sutures (Suture)
10/2009
1
Surgical Instruments (Clip)
10/2009